Literature DB >> 10480555

mRNA expression of complement components and regulators in rat arterial smooth muscle cells.

W Li1, T Tada, T Miwa, N Okada, J Ito, H Okada, H Tateyama, T Eimoto.   

Abstract

The presence of C5b-9 complexes, some complement regulators, and abundant cytokines in atherosclerotic lesions has been reported. However, it is unclear whether these complement-associated proteins are produced by vascular smooth muscle cells (SMCs) and how they are influenced by the cytokines. In the present study, we demonstrated, by the reverse transcription-polymerase chain reaction method, the mRNA expression of complement components (C3, C4, and C5) and membrane regulators (decay-accelerating factor, membrane cofactor protein, Crry, and CD59) in cultured SMCs derived from the rat carotid artery. The expression of C9 mRNA was also induced upon stimulation by interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and/or lipopolysaccharide (LPS). Northern blot analysis showed that the mRNA expression of C3, C4, DAF and Crry was up-regulated, but that of CD59 was down-regulated by IFN-gamma, TNF-alpha and/or LPS alone or by synergy. The increase of C3 mRNA by TNF-alpha or LPS and that of C4 mRNA by IFN-gamma was induced in a dose-dependent manner. The results indicate that the arterial SMCs of rat have the ability to produce complement components and regulators, which is affected by cytokines and/or LPS. Since atherosclerosis is characterized by the intimal proliferation of SMCs, the complement system including its regulators may be involved in the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480555     DOI: 10.1111/j.1348-0421.1999.tb02445.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

1.  The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury.

Authors:  Masashi Sakuma; Toshifumi Morooka; Yunmei Wang; Can Shi; Kevin Croce; Huiyun Gao; Michael Strainic; M Edward Medof; Daniel I Simon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-18       Impact factor: 8.311

Review 2.  Role of complement 3 in the pathogenesis of hypertension.

Authors:  Lan Chen; Noboru Fukuda; Taro Matsumoto; Masanori Abe
Journal:  Hypertens Res       Date:  2019-12-18       Impact factor: 3.872

3.  Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.

Authors:  David M Cauvi; Gabrielle Cauvi; K Michael Pollard
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

4.  Acquired genetic and functional alterations associated with transforming growth factor beta type I resistance in Hep3B human hepatocellular carcinoma cell line.

Authors:  Drazen B Zimonjic; Xiaoling Zhou; Ju-Seog Lee; Veronika Ullmannova-Benson; Veenu Tripathi; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  J Cell Mol Med       Date:  2009-05-01       Impact factor: 5.310

5.  Increased Complement 3 With Suppression of miR-145 Induces the Synthetic Phenotype in Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats.

Authors:  Lan Chen; Noboru Fukuda; Tomoyasu Otsuki; Sho Tanaka; Yoshihiro Nakamura; Hiroki Kobayashi; Taro Matsumoto; Masanori Abe
Journal:  J Am Heart Assoc       Date:  2019-05-21       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.